ARTICLE
|
doi:10.20944/preprints202307.1474.v1
Subject:
Medicine And Pharmacology,
Gastroenterology And Hepatology
Keywords:
Hepatocellular carcinoma; Atezolizumab–bevacizumab; Hepatic artery infusion chemotherapy; Overall survival; Progression-free survival
Online: 21 July 2023 (14:00:43 CEST)